By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews has extended the term of certain purchase warrants to July 31, 2012.

The warrants were issued by the Canadian molecular diagnostics firm on Jan. 16, 2009 and Feb. 11, 2009, entitling holders to purchase one common share of GeneNews at an exercise price of C$.25 ($US.25) per share.

There are 1 million warrants that were set to expire on Jan. 16, 2012, and there are 1,978,065 warrants that were set to expire on Feb. 11, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.